Eylea 2 MG/0.05 ML syringe 0.05ML
Ended Awarded
- Contract number
- SPE2DX25F6AFY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $29,335
Award facts
- Contract value 100% obligated
- $29,335.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.3K on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, which carries a firm fixed-price structure with no set-aside designation, is for the supply of Eylea 2 mg/0.05 ml syringes and is scheduled for completion by October 6, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, vaccines, and medical consumables distributed to Department of Defense healthcare sites nationwide. The company's expertise in pharmaceutical distribution, combined with its woman-owned small business status and substantial single-award contract vehicle with the Defense Logistics Agency, positions it as a preferred vendor for federal medical supply procurement. Eylea, an ophthalmic pharmaceutical used for retinal conditions, represents a specialized medical product consistent with the company's track record of supplying branded pharmaceutical solutions to military and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6AFY?
SPE2DX25F6AFY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 15, 2025.
How much is contract SPE2DX25F6AFY worth?
The government has obligated $29,335 on SPE2DX25F6AFY.
Is contract SPE2DX25F6AFY an order under another contract?
Yes. SPE2DX25F6AFY is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFY competed?
The extent of competition for SPE2DX25F6AFY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award